23 May 2013
Keywords: roche, neorecormon, gets, eu, approval, weekly, injection
Article | 15 January 2007
Swiss drug major Roche has received European marketing approval for a simple and convenient once weekly subcutaneous injection of NeoRecormon
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 January 2007
© 2013 thepharmaletter.com